Literature DB >> 28089125

Long-Term Outcomes of Permanent Cement Spacers in the Infected Foot.

Tammer Elmarsafi1, Noah G Oliver1, John S Steinberg2, Karen K Evans2, Christopher E Attinger2, Paul J Kim3.   

Abstract

When osteomyelitis occurs in the infected foot, cement spacers have been used as a limb salvage tool. The aim of the present study was to assess the longevity and outcomes in high-risk, low-demand patients who have undergone resection of bone and subsequent placement of permanent antibiotic-eluting cement spacers in the foot. A retrospective review case series of 30 patients who had undergone placement of a permanent antibiotic-eluting cement spacer in the foot were evaluated for retention, spacer exchange, removal, amputation, and functional status. The minimum follow-up time for inclusion was 12 months. Two thirds of all patients had successful spacers (n = 20) that were either retained (n = 14) or successfully exchanged (n = 6). One third of all patients experienced spacer failure (n = 10) and required removal. Of the 10 patients requiring spacer removal, 4 underwent removal with subsequent arthrodesis and 6 underwent removal with subsequent pseudoarthrosis. Also, 8 of these patients (26.7%) required partial foot amputation of the ipsilateral foot. These amputations were not directly related to the use or removal of the spacer. The average time to spacer removal or partial amputation was 20.9 (range 0.2 to 60.9) months. The longest retained spacer in the foot was 76 months at the last follow-up visit. The longest exchanged spacer at the last follow-up visit was 111 months. All surviving patients were ambulatory at the last follow-up visit.
Copyright © 2016 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amputation; bone cement; diabetes; infection; osteomyelitis; outcomes

Mesh:

Substances:

Year:  2017        PMID: 28089125     DOI: 10.1053/j.jfas.2016.10.022

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  5 in total

1.  Viability of permanent PMMA spacer with combined free fasciocutaneous tissue transfer for failed charcot reconstruction: A 38 month prospective case report.

Authors:  Tammer Elmarsafi; John S Steinberg; Paul J Kim; Christopher E Attinger; Karen K Evans
Journal:  Int J Surg Case Rep       Date:  2017-10-04

2.  CLINICAL EVALUATION OF PATIENTS WITH VANCOMYCIN SPACER RETAINED FOR MORE THAN 12 MONTHS.

Authors:  Leonardo Kurebayashi; Adauto Telino de Melo; Fernando Brandão Andrade-Silva; Kodi Edson Kojima; Jorge Dos Santos Silva
Journal:  Acta Ortop Bras       Date:  2019 Jan-Feb       Impact factor: 0.513

3.  Three-Stage Masquelet Technique and One-Stage Reconstruction to Treat Foot and Ankle Tuberculosis.

Authors:  Wenqiang Qu; Chi Wei; Li Yu; Yu Deng; Panfeng Fu; Zhe Kang; Shaobo Zhu
Journal:  Foot Ankle Int       Date:  2019-12-04       Impact factor: 2.827

4.  The Fate of Antibiotic Impregnated Cement Space in Treatment for Forefoot Osteomyelitis.

Authors:  Inha Woo; Jeongjin Park; Hyungyu Seok; Tae-gon Kim; Jun Sung Moon; Seung Min Chung; Chul Hyun Park
Journal:  J Clin Med       Date:  2022-04-01       Impact factor: 4.241

Review 5.  Local Antibiotic Delivery Systems in Diabetic Foot Osteomyelitis: A Brief Review.

Authors:  Christos Chatzipapas; Makrina Karaglani; Nikolaos Papanas; Konstantinos Tilkeridis; Georgios I Drosos
Journal:  Rev Diabet Stud       Date:  2021-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.